Agilon Health, Inc.

AGL · NYSE
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$110-$104$12-$106
Dep. & Amort.$7$7$7$6
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$15$17$2
Change in WC$93$53-$39$106
Other Non-Cash-$8-$6-$29$8
Operating Cash Flow-$18-$35-$32$16
Investing Activities
PP&E Inv.-$17-$6-$4-$3
Net Acquisitions$0$0$0$0
Inv. Purchases$0-$13-$48$0
Inv. Sales/Matur.$35$90$35$40
Other Inv. Act.$0-$1-$7-$13
Investing Cash Flow$19$70-$23$24
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$0-$0
Stock Repurch.-$0-$3-$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow-$0-$3-$0-$0
Forex Effect$0$0$0$0
Net Chg. in Cash$0$33-$55$40
Supplemental Information
Beg. Cash$171$139$194$154
End Cash$172$171$139$194
Free Cash Flow-$21-$38-$43$4
Agilon Health, Inc. (AGL) Financial Statements & Key Stats | AlphaPilot